help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poirier, P.
Right arrow Articles by Nadeau, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poirier, P.
Right arrow Articles by Nadeau, A.
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 8 2860-2864
Copyright © 2000 by The Endocrine Society


Original Studies

Impact of Time Interval from the Last Meal on Glucose Response to Exercise in Subjects with Type 2 Diabetes1

Paul Poirier2, Angelo Tremblay, Claude Catellier, Gilles Tancrède, Caroline Garneau and André Nadeau

Québec Heart Institute at Laval Hospital (C.G., P.P.), Diabetes Research Unit, Centre Hospitalier Universitaire de Québec, Pavillon CHUL (P.P., C.C., G.T., A.N.), Physical Activity Sciences Laboratory (A.T.), and Laval University, Sainte Foy, Québec, Canada G1V 4G5

Address all correspondence and requests for reprints to: Paul Poirier, M.D., F.R.C.P.C., Québec Heart Institute, Laval Hospital, 2725 Chemin Sainte Foy, Sainte Foy, Québec, Canada G1V 4G5. E-mail: paul.poirier{at}crhl.ulaval.ca


    Abstract
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
We evaluate the influence of the time interval from the last meal on the blood glucose response to exercise in men with type 2 diabetes. Nineteen men with type 2 diabetes participated in an exercise training program carried out at 60% of maximal oxygen uptake (VO2peak) for 1 h, 3 times a week. Capillary whole blood glucose was measured immediately before and after each exercise session, and the time interval from the last meal (breakfast, lunch, or dinner) was recorded. Seven time intervals were considered (fasted overnight and 0–1, 1–2, 2–3, 3–4, 4–5, and 5–8 h postmeal). A total of 1045 exercise sessions were analyzed. There was no change in blood glucose levels when individuals were in the fasted state (mean ± SE, 8.1 ± 0.2 vs. 8.1 ± 0.1 mmol/L; before vs. after, respectively). However, blood glucose decreased by 28 ± 1% at 0–1 h, by 33 ± 1% at 1–2 h, by 35 ± 1% at 2–3 h, by 38 ± 2% at 3–4 h, by 43 ± 2% at 4–5 h, and by 23 ± 3% at 5–8 h (all P < 0.001). These results demonstrate that 1 h of ergocycle exercise has no clinical impact on blood glucose when performed in the fasted state in men with type 2 diabetes, whereas a significant decrease in blood glucose should be expected when the same exercise is performed postprandially.


    Introduction
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
AEROBIC EXERCISE training has long been considered an important part of the treatment of subjects with type 2 diabetes (1). Indeed, exercise may improve cardiovascular fitness and assist in decreasing blood glucose levels (2). Nevertheless, little information is available regarding the glucose level changes that occur in subjects with type 2 diabetes after an acute bout of exercise in relation to the time interval from the last meal.

Exercise-induced hypoglycemia in subjects with type 2 diabetes treated with sulfonylureas is a practical concern. Health care professionals are reluctant to instruct subjects with type 2 diabetes to exercise in the fasted state, even though hypoglycemia during exercise tends to be less of a problem in this population than in subjects with type 1 diabetes (2). In contrast to the belief of many practitioners (3, 4, 5, 6, 7, 8), several studies in subjects with type 2 diabetes have shown that acute exercise has only a modest impact on blood glucose when it is performed in the fasted state (3, 4, 5, 9, 10, 11). Moreover, there is only one published study that has investigated the effect of exercise on serial glucose levels depending on the time interval from the last meal (12). In that particular study, subjects with type 2 diabetes were treated with diet only, and the observations made may not reflect what happens in subjects with a more severe diabetic state requiring oral hypoglycemic agents for their proper management. The present study was thus undertaken to examine the impact of a 1-h exercise bout on the blood glucose status of subjects with type 2 diabetes treated with diet and oral hypoglycemic agents. More specifically, the influence on blood glucose of different time intervals between the last meal and the exercise session was evaluated in a cohort of subjects with type 2 diabetes involved in an aerobic physical training program (13).


    Subjects and Methods
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Subjects

Subjects with type 2 diabetes were enrolled in a training program protocol that investigated the effect of physical training on lipid profile (13). For safety purposes and to motivate the participants, whole blood glucose levels were measured immediately before and after each exercise session. Nineteen men with type 2 diabetes gave written consent to participate in the protocol, which was approved by the ethics committee of Laval University. They had no clinical evidence of diabetic complications or renal, hepatic, or thyroid diseases. A normal treadmill exercise test (supervised by a cardiologist) was a prerequisite for participation in the study. None of the subjects was being treated with insulin. Except for one subject treated with diet only, all other subjects (n = 18) were treated with diet plus oral hypoglycemic agents (glyburide and/or metformin). Specifically, nine subjects were treated with glyburide alone, two were treated with metformin alone, and seven were using a combination of both agents. None was involved in a regular exercise program for the 6 months before entering the study. All participants were instructed not to change their usual dietary habits during the training period. Fasting blood was drawn from all subjects before the exercise program for the measurement of glycated hemoglobin (14).

Measurement of total body fat

Percent body fat was calculated from body density measured by hydrostatic weighing using the equation of Siri (15). Fat mass was obtained by multiplying percent body fat by body weight.

Exercise protocol

Exercise was performed three times a week, and all sessions were under the direct supervision of an exercise physiologist. Each session consisted of exercising on a vertical ergometer (Monark, Stockholm, Sweden) at a workload corresponding to 60% of maximal oxygen uptake (VO2peak). The intensity level was prescribed and monitored on the basis of heart rate. The appropriate heart rate was determined using the results of the VO2peak test. Exercise duration was fixed at 30 and 45 min/session during weeks 1 and 2, respectively. From week 3, all subjects exercised for 60 min/session. The data reported here include values for all of these 60-min exercise sessions. The measurement of maximal oxygen uptake was repeated after 3 months of training, and the exercise session target heart rate was adjusted accordingly for the following 3 months. Whole blood glucose was measured by each participant under supervision of the exercise physiologist, immediately before and within 5 min after the end of each exercise session with a glucometer (One Touch, Lifescan, Inc., Burnaby, BC, Canada). The same glucometer was used throughout the study duration, and proper calibration procedures were followed according to the manufacturer. Exercise sessions were performed between 0600–0900 h or later during the day (between 1600–2000 h). The time interval between the last meal (breakfast, lunch, or dinner) and the exercise session was recorded by the exercise physiologist. Subjects who exercised in the fasted state did not take their oral hypoglycemic agents before the exercise session. Subjects attended different training sessions.

Statistical analysis

The data are presented as the mean ± SE unless otherwise specified. One-way ANOVA was used to compare time interval differences. When normality and/or equal variance testing conditions were not met, the Kruskal-Wallis rank-sum test and/or Dunn’s test for multiple comparisons were used, respectively. Pre- and postexercise glucose level comparisons were performed using Student’s paired t test. P <= 0.05 was considered statistically significant.


    Results
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
The characteristics of the 19 subjects before the training program are shown in Table 1Go. The known duration of their diabetes ranged from 3 months to 20 yr. As shown by the glycated hemoglobin level, diabetes was not well controlled in many subjects at the beginning of the study. All subjects were sedentary, with a baseline VO2peak of 31.5 ± 5.7 mL/kg·min.


View this table:
[in this window]
[in a new window]
 
Table 1. Characteristics of the subjects before the training program (n = 19)

 
The results reflect the pooled data from the participants throughout the program. Whole blood glucose levels were recorded from 1045 1-h exercise sessions, and 7 time intervals between the exercise session and the last meal were considered (fasted overnight and 0–1, 1–2, 2–3, 3–4, 4–5, and 5–8 h postmeal). Table 2Go depicts the number of subjects, the number of exercise sessions, the percentage of target heart rate attained, and the percentage of blood glucose decrease from baseline for each time interval. The percentage of target heart rate attained was slightly lower when exercise was performed in the fasted state or during the first hour following a meal (Table 2Go). Interestingly, the decrease in blood glucose from baseline was most pronounced when exercise was performed 3–5 h after the last meal (Table 2Go).


View this table:
[in this window]
[in a new window]
 
Table 2. Characteristics of the 1045 exercise sessions per time intervals in subjects with type 2 diabetes

 
Figure 1Go shows the glucose levels before and after aerobic exercise at different time intervals from the last meal. There was no change in whole blood glucose levels (before vs. after) after exercise when participants were in the fasted state (mean ± SE, 8.1 ± 0.2 vs. 8.1 ± 0.1 mmol/L, respectively). However, when participants had consumed a meal before exercise, blood glucose levels decreased significantly (P < 0.001). Of particular interest is that even if preexercise blood glucose levels were comparable in the fasted state and 5–8 h postprandially, blood glucose levels decreased significantly only in subjects who were in the postprandial state (8.2 ± 0.4 decreasing to 6.0 ± 0.2 mmol/L; P < 0.001). Moreover, the blood glucose response to exercise in relation to the previous meal did not differ between the first 3 months and the last 3 months of the exercise training protocol (data not shown). No subject suffered from clinical hypoglycemia during the exercise session. However, few exercise sessions (n = 14) ended with a blood glucose level of 3.3 mmol/L or less (range, 2.8–3.3 mmol/L), and all of them were carried out in the postprandial state.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 1. Glucose levels before and after 1 h of aerobic exercise at 60% of VO2peak based on the time interval from the last meal (fasted overnight, n = 80 sessions; 0–1 h, n = 351 sessions; 1–2 h, n = 254 sessions; 2–3 h, n = 88 sessions; 3–4 h, n = 126 sessions; 4–5 h, n = 102 sessions; 5–8 h, n = 44 sessions). *, P < 0.001, before vs. after.

 
To lessen the impact of the number of exercise sessions performed per individual in each time interval, the averaged blood glucose changes for each subject for each time interval were compared. Results remained essentially the same. There was no significant change in whole blood glucose levels (before vs. after) after exercise in the fasted state (8.6 ± 0.6 vs. 8.1 ± 0.5 mmol/L; P = 0.536). However, subjects showed a significant decrease in blood glucose levels after exercise at 0–1 h (10.7 ± 0.6 vs. 7.5 ± 0.5 mmol/L), 1–2 h (10.8 ± 0.7 vs. 7.0 ± 0.5 mmol/L), 2–3 h (10.0 ± 1.1 vs. 6.2 ± 0.7 mmol/L), 3–4 h (10.1 ± 0.8 vs. 6.2 ± 0.4 mmol/L), 4–5 h (9.2 ± 0.8 vs. 5.5 ± 0.4 mmol/L; all P < 0.001), and 5–8 h (9.0 ± 1.0 vs. 6.1 ± 0.5 mmol/L; P = 0.003). Furthermore, we analyzed our data on the basis of treatment for diabetes. We separated our group into three subgroups; 1) glyburide alone, 2) glyburide plus metformin, and 3) metformin plus diet alone. The results held firm. There was no significant decrease in capillary blood glucose when subjects exercised while fasting in each group: glyburide alone, 7.6 ± 0.2 vs. 7.6 ± 0.2 mmol/L; glyburide plus metformin, 7.8 ± 0.2 vs. 7.9 ± 0.2 mmol/L; and metformin plus diet, 9.2 ± 0.3 vs. 9.0 ± 0.3 mmol/L.

To provide further evidence, we isolated data from four subjects who performed at least nine exercise sessions in the fasted state and at 0–1 h postprandially. These individuals performed 76% of the total of all exercise sessions carried out in the fasted state and 49% of all exercise sessions carried out 0–1 h after a meal. Again, blood glucose levels did not decrease significantly when exercise was performed in the fasted state (7.7 ± 0.2 vs. 7.8 ± 0.1 mmol/L, before vs. after, respectively) in contrast to a significant decrease seen at 0–1 h (10.1 ± 0.2 vs. 7.6 ± 0.1 mmol/L; P < 0.001).


    Discussion
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
This study demonstrates that 1 h of exercise performed at about 60% VO2peak did not decrease whole blood glucose levels when performed in the fasted state by men with type 2 diabetes treated with diet and oral hypoglycemic agents. However, a decrease of 20–40% from baseline was experienced when exercise was performed in the postprandial state.

These results agree with previous investigations that have shown no major effect of exercise on blood glucose when exercise is performed in the fasted state by subjects with type 2 diabetes (3, 4, 5, 10), in contrast to the frequent belief of many health care professionals. Apart from the nutritional status, numerous factors, such as the intensity and duration of the exercise session, the type of treatment, and metabolic control, may also influence the blood glucose response after exercise in subjects with type 2 diabetes.

Indeed, exercise intensity and duration interact with regard to the decline in plasma glucose concentrations in subjects with type 2 diabetes. It has been shown that changes in plasma glucose levels are similar after 70 min of exercise at 50% VO2peak compared to 50 min at 70% of VO2peak (7). Furthermore, it has been clearly demonstrated that the longer the exercise session, the greater the decline in blood glucose levels when exercise is performed at the same intensity in subjects with type 2 diabetes (11). Looking at the type of treatment and blood glucose control, the glycemic response to exercise tends to be greater in patients treated with diet only than in those treated with oral hypoglycemic agents (9, 11). Moreover, the decline from baseline glucose is greater in subjects who start exercise with higher fasting blood glucose (7, 8, 11). In this regard, it is of interest to note that in the present study subjects who exercised 5–8 h after a meal decreased their blood glucose much more than those who exercised in the fasted state, even if they had similar preexercise blood glucose levels. Although blood glucose decreases with increasing time interval from the last meal, exercise still potentiates the blood glucose decline seen normally after a meal in all time periods considered. The percentage of target heart rate achieved was approximately 5% lower in subjects who exercised in the fasted state than in those who had consumed a meal 5–8 h before exercise. However, the percentage of target heart rate was also about 5% lower in subjects who exercised at 0–1 h after the ingested meal, but those individuals nevertheless experienced a significant decrease in blood glucose levels. Considering results from previous investigations (3, 4, 5, 9, 10, 11), it is unlikely that the 5% lower percentage of target heart rate could account for the difference in results between subjects who exercised in the fasted state and postprandially.

There is a potential increased risk of hypoglycemia with exercise in patients with type 2 diabetes receiving sulfonylurea therapy. The risk is generally perceived by clinicians to be greater when exercise is performed in the fasted state (4, 5, 10). However, in daily life, physical exercise is usually performed in the postprandial rather than the fasted state. Because hypoglycemia can precipitate myocardial ischemia (16), knowledge about the expected decline in blood glucose after exercise is important. Thus, it is primordial to know the impact of the nutritional status on blood glucose response after exercise. It has been reported that with concomitant oral agent administration, exercise performed 1 h in the postprandial state (breakfast) decreased blood glucose levels by 10–15%, and only a few subjects experienced hypoglycemia in a cohort of subjects with well controlled type 2 diabetes (17). On the other hand, no significant decrease in blood glucose was observed in other studies in subjects with well controlled type 2 diabetes when exercise was performed in the fasted state when the subjects had not taken their usual oral hypoglycemic agents for at least 36 h before the study (4, 5). In the present study subjects had not taken their medication before exercising in the fasted state, as usually advised in such situation. Moreover, due to the long duration of action of glyburide (16–24 h), this medication was probably still acting in some subjects (18). Blood glucose levels were examined in those (n = 5) who had taken glyburide at dinner the day before exercise and in those (n = 5) who did not. There was no difference between those two subgroups of subjects in the blood glucose change with exercise. Moreover, the treatment for diabetes does not seem to influence the blood glucose response to exercise while fasting. It is important to note that subjects from previous studies and the present one were mildly hyperglycemic (8–12 mmol/L) before the exercise session in the fasted state and that no hypoglycemia occurred in these individuals as in the present study (3, 4, 5, 6, 7, 8, 9, 10, 11, 12). Of interest, in the present study the few exercise sessions that ended with the lowest blood glucose levels were encountered when subjects performed exercise in the fed state.

Regular exercise is considered one of the cornerstones in the management of patients with type 2 diabetes. Indeed, exercise is recommended as a nonpharmacological means to improve lipid profile (13) and insulin sensitivity (2, 19). However, long-term compliance to an exercise program is low (20, 21), and motivation incentive needs to be developed. Lowering of blood glucose may be used as part of the motivation, and knowledge about the degree of lowering that can be expected postprandially with exercise will help both in motivating subjects to exercise regularly and in prescribing a safe exercise program.

Limitations

Numerous variables may have influenced the response to exercise. Unfortunately, the study design does not allow us to assess the macronutrient and calorie compositions of each meal. Although there is important variability in the blood glucose responses related to a particular meal in subjects with type 2 diabetes, this study was intended to be representative of an out-patient setting. The present study does not allow uncovering the mechanism by which blood glucose levels decreased when exercise is performed after a meal in contrast to the fasted state, when blood glucose levels did not change significantly. Nevertheless, one possible explanation could be that the hepatic glucose production is diminished by the meal-induced insulin response, thereby creating an imbalance between glucose production and glucose utilization in the fed state and causing a decline in blood glucose levels (12, 22, 23). Conversely, stable insulin levels in the fasted state may allow the increased glucose utilization to be adequately matched by a parallel increase in glucose production, which results in a blunted blood glucose decline. Obviously, further research is needed to determine the underlying mechanism behind our observations to optimize the impact of exercise on glucose control in subjects with type 2 diabetes. Of interest, however, is that these observations were obtained in an out-patient clinical settings, such as these patients and health care professionals use to interact daily. Obviously, further research with standardized meal, similar drug regimens, and formal ascertainment of time interval from meal to exercise and/or drug intake is needed to determine the underlying mechanism behind our observations to optimize the impact of exercise on glucose control in subjects with type 2 diabetes.

In summary, the results of this study conducted in men with type 2 diabetes have shown that 1 h of ergocycle does not cause a decrease in whole blood glucose when performed in the fasted state before taking the oral agents, whereas it does so when the same exercise stimulus is applied after a meal. Thus, contrary to a frequent belief, the risk of a hypoglycemic event may be greater when subjects with type 2 diabetes performed exercise after a meal than in the fasted state, although no serious events occurred with the 1045 exercise sessions reported in the present study.


    Acknowledgments
 
We appreciated the assistance of H. Bessette with the measurement of maximal oxygen uptake. We also thank Dr. R. Larouche (deceased) for exercise testing. We express our gratitude to Dr. William T. Donahoo for interesting discussion during the preparation of this manuscript.


    Footnotes
 
1 This work was supported by Health and Welfare Canada. Back

2 Recipient of a Medical Research Council of Canada studentship. Back

Received November 15, 1999.

Revised April 21, 2000.

Accepted May 14, 2000.


    References
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 

  1. Lawrence RH. 1926 The effects of exercise on insulin action in diabetes. Br Med J. 1:648–650.[Free Full Text]
  2. American College of Sports Medicine and American Diabetes Association. 1997 Joint position statement. Diabetes mellitus and exercise. Med Sci Sports Exerc. 29:i–vi.
  3. Colberg SR, Hagberg JM, McCole SD, Zmuda JM, Thompson PD, Kelley DE. 1996 Utilization of glycogen but not plasma glucose is reduced in individuals with NIDDM during mild-intensity exercise. J Appl Physiol. 81:2027–2033.[Abstract/Free Full Text]
  4. Riddle MC, McDaniel PA, Tive LA. 1997 Glipizide-GITS does not increase the hypoglycemic effect of mild exercise during fasting in NIDDM. Diabetes Care. 20:992–994.[Abstract]
  5. Jenkins AB, Furler SM, Bruce DG, Chisholm DJ. 1988 Regulation of hepatic glucose output during moderate exercise in non-insulin-dependent diabetes. Metabolism. 37:966–972.[CrossRef][Medline]
  6. Koivisto VA, DeFronzo RA. 1984 Exercise in the treatment of type II diabetes. Acta Endocrinol (Copenh). Suppl262 :107–111.
  7. Kang J, Kelley DE, Robertson RJ, et al. 1999 Substrate utilization and glucose turnover during exercise of varying intensities in individuals with NIDDM. Med Sci Sports Exerc. 31:82–89.[Medline]
  8. Minuk HL, Vranic M, Marliss EB, Hanna AK, Albisser AM, Zinman B. 1981 Glucoregulatory and metabolic response to exercise in obese noninsulin-dependent diabetes. Am J Physiol. 240:E458–E464.
  9. Martin IK, Katz A, Wahren J. 1995 Splanchnic and muscle metabolism during exercise in NIDDM patients. Am J Physiol. 269:E583–E590.
  10. Gudat U, Bungert S, Kemmer F, Heinemann L. 1998 The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus. Diabet Med. 15:194–198.[CrossRef][Medline]
  11. Paternostro-Bayles M, Wing RR, Robertson RJ. 1989 Effect of life-style activity of varying duration on glycemic control in type II diabetic women. Diabetes Care. 12:34–37.[Abstract]
  12. Larsen JJ, Dela F, Kjaer M, Galbo H. 1997 The effect of moderate exercise on postprandial glucose homeostasis in NIDDM patients. Diabetologia. 40:447–453.[CrossRef][Medline]
  13. Poirier P, Catellier C, Tremblay A, Nadeau A. 1996 Role of body fat loss in the exercise-induced improvement of the plasma lipid profile in non-insulin-dependent diabetes mellitus. Metabolism. 45:1383–1387.[CrossRef][Medline]
  14. Trivelli LA, Ranney HM, Lai HT. 1971 Hemoglobin components in patients with diabetes mellitus. N Engl J Med. 284:353–357.
  15. Siri WE. 1956 The gross composition of the body. Adv Biol Med Phys. 4:239–280.[Medline]
  16. Duh E, Feinglos M. 1994 Hypoglycemia-induced angina pectoris in a patient with diabetes mellitus. Ann Intern Med. 121:945–946.[Free Full Text]
  17. Massi-Benedetti M, Herz M, Pfeiffer C. 1996 The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide. Horm Metab Res. 28:451–455.[Medline]
  18. DeFronzo RA. 1999 Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med. 131:281–303.[Abstract/Free Full Text]
  19. Poirier P, Broderick TL, Tremblay A, Catellier C, Nadeau A. 1991 Physical training does not improve insulin sensitivity in obese NIDDM men. Diabetes. 40:397A.
  20. Skarfors ET, Wegener TA, Lithell H, Selinus I. 1987 Physical training as treatment for type 2 (non-insulin-dependent) diabetes in elderly men. A feasibility study over 2 years. Diabetologia. 12:930–933.
  21. Schneider SH, Khachadurian AK, Amorosa LF, Clemow L, Ruderman NB. 1992 Ten-year experience with an exercise-based outpatient life-style modification program in the treatment of diabetes mellitus. Diabetes Care. 15:1800–1810.[Abstract]
  22. Sindelar DK, Chu CA, Venson P, Donahue EP, Neal DW, Cherrington AD. 1998 Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes. 47:523–529.[Abstract]
  23. Nadeau A, Poirier P, Grondin L, Cléroux J, Tremblay A, Catellier C. 1990 Enhanced plasma glucose lowering effect of exercise by prior breakfast in type II diabetic men. Diabetes. 39:73A.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poirier, P.
Right arrow Articles by Nadeau, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poirier, P.
Right arrow Articles by Nadeau, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals